| Literature DB >> 31783772 |
Arun Sudhagar1,2, Reinhard Ertl3, Gokhlesh Kumar4, Mansour El-Matbouli1.
Abstract
BACKGROUND: Tetracapsuloides bryosalmonae is a myxozoan parasite which causes economically important and emerging proliferative kidney disease (PKD) in salmonids. Brown trout, Salmo trutta is a native fish species of Europe, which acts as asymptomatic carriers for T. bryosalmonae. There is only limited information on the molecular mechanism involved in the kidney of brown trout during T. bryosalmonae development. We employed RNA sequencing (RNA-seq) to investigate the global transcriptome changes in the posterior kidney of brown trout during T. bryosalmonae development.Entities:
Keywords: Gene expression; Myxozoan; RNA-seq; Salmonids; Tetracapsuloides bryosalmonae
Mesh:
Year: 2019 PMID: 31783772 PMCID: PMC6884850 DOI: 10.1186/s13071-019-3823-y
Source DB: PubMed Journal: Parasit Vectors ISSN: 1756-3305 Impact factor: 3.876
Fig. 1Histological sections of brown trout posterior kidney. a Tetracapsuloides bryosalmonae-exposed posterior kidney section shows T. bryosalmonae (arrows) proliferation, pronounced tubular degeneration and reduction of melanomacrophages at 12 weeks post-exposure (H&E staining). b Immunohistostaining shows interstitial extrasporogonic stages of T. bryosalmonae (arrows) in the posterior kidney. c No parasite or any renal changes were observed in the unexposed posterior control kidney (H&E staining). Scale-bars: 20 µm
Description of transcriptome data of Tetracapsuloides bryosalmonae-exposed and unexposed control posterior kidney of brown trout
| Samples | Total no. of reads | No. of trimmed reads | Mapping with rainbow trout reference genome | Mapping with Atlantic salmon reference genome | Mapping with brown trout reference transcriptome | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No. of mapped reads | % of mapped reads | No. of unmapped reads | % unmapped reads | No. of mapped reads | % of mapped reads | No. of unmapped reads | % unmapped reads | No. of mapped reads | % of mapped reads | No. of unmapped reads | % unmapped reads | |||
| Control 1 | 37,453,251 | 37,432,308 | 28,587,181 | 76.37 | 8,845,127 | 23.63 | 31,555,799 | 84.3 | 5,876,509 | 15.7 | 33,957,176 | 90.72 | 3,475,132 | 9.28 |
| Control 2 | 36,014,039 | 36,000,623 | 27,596,056 | 76.65 | 8,404,567 | 23.35 | 30,167,749 | 83.8 | 5,832,874 | 16.2 | 32,695,497 | 90.82 | 3,305,126 | 9.18 |
| Control 3 | 33,756,491 | 33,742,632 | 25,599,517 | 75.87 | 8,143,115 | 24.13 | 28,588,179 | 84.72 | 5,154,453 | 15.28 | 30,631,472 | 90.78 | 3,111,160 | 9.22 |
| Control 4 | 28,906,028 | 28,893,551 | 22,082,023 | 76.43 | 6,811,528 | 23.57 | 24,154,386 | 83.6 | 4,739,165 | 16.4 | 26,126,636 | 90.42 | 2,766,915 | 9.58 |
| Control 5 | 35,936,239 | 35,917,599 | 27,065,039 | 75.35 | 8,852,560 | 24.65 | 30,203,792 | 84.09 | 5,713,807 | 15.91 | 32,698,686 | 91.04 | 3,218,913 | 8.96 |
| Control 6 | 35,784,560 | 35,769,721 | 27,665,605 | 77.34 | 8,104,116 | 22.66 | 30,149,740 | 84.29 | 5,619,981 | 15.71 | 32,632,620 | 91.23 | 3,137,101 | 8.77 |
| Exposed 1 | 36,037,693 | 36,021,748 | 26,712,983 | 74.16 | 9,308,765 | 25.84 | 30,604,349 | 84.96 | 5,417,399 | 15.04 | 32,234,190 | 89.49 | 3,787,558 | 10.51 |
| Exposed 2 | 36,585,106 | 36,570,194 | 27,967,577 | 76.48 | 8,602,617 | 23.52 | 30,928,270 | 84.57 | 5,641,924 | 15.43 | 33,142,773 | 90.63 | 3,427,421 | 9.37 |
| Exposed 3 | 34,790,815 | 34,777,577 | 26,339,581 | 75.74 | 8,437,996 | 24.26 | 29,540,271 | 84.94 | 5,237,306 | 15.06 | 31,484,762 | 90.53 | 3,292,815 | 9.47 |
| Exposed 4 | 34,863,462 | 34,848,992 | 26,601,431 | 76.33 | 8,247,561 | 23.67 | 29,178,501 | 83.73 | 5,670,491 | 16.27 | 31,894,763 | 91.52 | 2,954,229 | 8.48 |
| Exposed 5 | 35,989,820 | 35,973,511 | 27,781,132 | 77.23 | 8,192,379 | 22.77 | 30,067,422 | 83.58 | 5,906,089 | 16.42 | 32,541,899 | 90.46 | 3,431,612 | 9.54 |
| Exposed 6 | 35,705,332 | 35,687,549 | 27,935,659 | 78.28 | 7,751,890 | 21.72 | 29,067,347 | 81.45 | 6,620,202 | 18.55 | 32,373,706 | 90.71 | 3,313,843 | 9.29 |
Notes: Filtered clean reads were mapped against the available genomes of rainbow trout and Atlantic salmon, and brown trout reference transcriptome
Fig. 2Global correlation matrix of gene expression levels between samples. Heatmap showing Pearsonʼs correlation coefficient (r) for log2 (TPM + 1) normalized RNA-seq values across samples, indicating positive correlation between biological replicates
Fig. 3Volcano plot of differently expressed genes of posterior kidney. x-axis represents log2 transformed fold change and the y-axis indicates − log10 transformed adjusted significance. Each dot indicates an individual gene that is significantly upregulated genes (blue), downregulated genes (red) and non-significantly regulated genes (green). The horizontal line represents adjusted P-value < 0.01 cut-off and the vertical lines represent the absolute value of fold change greater than or equal to two
Fig. 4Heatmap visualization and hierarchical clustering of selected 30 differentially expressed genes. The heatmap displays selected 30 differentially expressed genes between Tetracapsuloides bryosalmonae-exposed and unexposed control brown trout posterior kidney selected based on adjusted P-value, sample and feature. Hierarchical clustering was performed using the single linkage method based on Euclidean distance matrix. Each column represents a posterior kidney sample and each row represents a gene
Distribution of the differentially expressed genes in immune related pathways categorized from the KEGG pathway database
| Sl No | Pathway ID | Pathway | No. of genes |
|---|---|---|---|
| 1 | ko04062 | Chemokine signaling | 12 |
| 2 | ko04621 | NOD-like receptor signaling | 10 |
| 3 | ko04650 | Natural killer cell mediated cytotoxicity | 9 |
| 4 | ko04620 | Toll-like receptor signaling | 9 |
| 5 | ko04625 | C-type lectin receptor signaling | 9 |
| 6 | ko04659 | Th17 cell differentiation | 8 |
| 7 | ko04640 | Hematopoietic cell lineage | 8 |
| 8 | ko04662 | B cell receptor signaling | 7 |
| 9 | ko04670 | Leukocyte transendothelial migration | 6 |
| 10 | ko04658 | Th1 and Th2 cell differentiation | 6 |
| 11 | ko04610 | Complement and coagulation cascades | 6 |
| 12 | ko04672 | Intestinal immune network for IgA production | 5 |
| 13 | ko04660 | T cell receptor signaling | 5 |
| 14 | ko04666 | Fc gamma R-mediated phagocytosis | 5 |
| 15 | ko04622 | RIG-I-like receptor signaling | 4 |
| 16 | ko04657 | IL-17 signaling | 4 |
| 17 | ko04611 | Platelet activation | 4 |
| 18 | ko04612 | Antigen processing and presentation | 3 |
| 19 | ko04623 | Cytosolic DNA-sensing | 3 |
| 20 | ko04624 | Toll and Imd signaling | 2 |
| 21 | ko04664 | Fc epsilon RI signaling | 2 |
Notes: The pathway analysis mapped 571 out of 1169 DEGs (48.8%) to 282 pathways, including 21 immune system pathways in the KEGG database
List of the differentially expressed genes mapped to representative immune-related pathways by KEGG pathway analysis
| Sl no | Gene code | Description | Fold change | Regulation |
|---|---|---|---|---|
| Chemokine signaling | ||||
| 1 | ADCY9 | Adenylate cyclase type 9 | 3.59 | Up |
| 2 | CCL11 | C-C motif chemokine 11/eotaxin | 9.56 | Up |
| 3 | CCL4 | C-C motif chemokine 4 | 13.42 | Up |
| 4 | CCR5 | C-C chemokine receptor type 5-like | 4.31 | Up |
| 5 | CXCL12 | Stromal cell-derived factor 1 precursor | 3.0 | Up |
| 6 | CXCL13 | C-X-C motif chemokine 13-like | 4.99 | Up |
| 7 | CXCR1 | C-X-C chemokine receptor type 1-like | 4.47 | Up |
| 8 | CXCR3 | C-X-C chemokine receptor type 3-like | − 2.49 | Down |
| 9 | CXCR5 | C-X-C chemokine receptor type 5-like | 2.64 | Up |
| 10 | FOXO3 | Forkhead box O3 | 4.36 | Up |
| 11 | GNG13 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-13 | 3.53 | Up |
| 12 | PXN | Paxillin-like | 3.11 | Up |
| NOD-like receptor signaling | ||||
| 1 | ATG16L1 | Autophagy related 16-like 1 | 2.88 | Up |
| 2 | ATG5 | Autophagy related 5 homolog | 4.89 | Up |
| 3 | CASR | Extracellular calcium-sensing receptor-like protein | 3.26 | Up |
| 4 | CTSB | Cathepsin B | − 3.01 | Down |
| 5 | IFNAR1 | Interferon alpha/beta receptor 1a-like | 2.34 | Up |
| 6 | IFNAR2 | Interferon alpha/beta receptor 2 | 2.72 | Up |
| 7 | JUN | Transcription factor AP-1-like | 3.75 | Up |
| 8 | NLRP3 | NACHT, LRR and PYD domains-containing protein 3 | − 2.37 | Down |
| 9 | PYCARD | Apoptosis-associated speck-like protein containing a CARD | 2.53 | Up |
| 10 | RIPK3 | Receptor-interacting serine/threonine-protein kinase 3 | 2.70 | Up |
| Natural killer cell mediated cytotoxicity | ||||
| 1 | BID | BH3-interacting domain death agonist-like | 2.77 | Up |
| 2 | ICAM1 | Intercellular adhesion molecule 1-like isoform X2 | − 7.45 | Down |
| 3 | IFNAR1 | Interferon alpha/beta receptor 1a-like | 2.34 | Up |
| 4 | IFNAR2 | Interferon alpha/beta receptor 2 | 2.72 | Up |
| 5 | IFNGR1 | Interferon gamma receptor 1a | 2.33 | Up |
| 6 | IGH | Immunoglobulin heavy chain | 147.29 | Up |
| 7 | ITGB2 | Integrin beta-2-like | 3.0 | Up |
| 8 | PRF1 | Perforin-1-like | − 3.18 | Down |
| 9 | PTPN11 | Tyrosine-protein phosphatase non-receptor type 11 | 2.81 | Up |
| Th17 cell differentiation | ||||
| 1 | CD3E | CD3epsilon | 5.68 | Up |
| 2 | IFNGR1 | Interferon gamma receptor 1a | 2.33 | Up |
| 3 | IL21R | Interleukin-21 receptor-like | 2.69 | Up |
| 4 | IL6ST | Interleukin-6 receptor subunit beta-like | 3.28 | Up |
| 5 | IRF4 | Interferon regulatory factor 4 | 7.28 | Up |
| 6 | JUN | Transcription factor AP-1-like | 3.75 | Up |
| 7 | NFKBIE | Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 9.05 | Up |
| 8 | TGFBR1 | TGF-beta receptor type-1 | − 2.14 | Down |
| Hematopoietic cell lineage | ||||
| 1 | CD2 | T-cell surface antigen CD2 | 2.89 | Up |
| 2 | CD22 | B-cell receptor CD22-like | 3.10 | Up |
| 3 | CD34 | Hematopoietic progenitor cell antigen CD34-like | − 3.13 | Down |
| 4 | CD3E | CD3epsilon | 5.68 | Up |
| 5 | CR2 | Complement receptor type 2-like | 3.25 | Up |
| 6 | IGH | Immunoglobulin heavy chain | 147.29 | Up |
| 7 | MME | Neprilysin-like | − 4.06 | Down |
| 8 | TFRC | Transferrin receptor protein 1-like | 4.97 | Up |
| B cell receptor signaling | ||||
| 1 | BLNK | B-cell linker protein-like isoform X1 | 3.43 | Up |
| 2 | CD22 | B-cell receptor CD22-like | 3.10 | Up |
| 3 | CD79A | B-cell antigen receptor complex-associated protein alpha chain-like | 2.76 | Up |
| 4 | CR2 | Complement receptor type 2-like | 3.25 | Up |
| 5 | IGH | Immunoglobulin heavy chain | 147.29 | Up |
| 6 | JUN | Transcription factor AP-1-like | 3.75 | Up |
| 7 | NFKBIE | Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 9.05 | Up |
| Th1 and Th2 cell differentiation | ||||
| 1 | CD3E | CD3 epsilon | 5.68 | Up |
| 2 | IFNGR1 | Interferon gamma receptor 1a | 2.33 | Up |
| 3 | IL12B | Interleukin-12 subunit beta-like | 2.31 | Up |
| 4 | IL12RB2 | Interleukin-12 receptor subunit beta-2-like | 3.50 | Up |
| 5 | JUN | Transcription factor AP-1-like | 3.75 | Up |
| 6 | NFKBIE | Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 9.05 | Up |
| Complement and coagulation cascades | ||||
| 1 | A2M | Alpha-2-macroglobulin-like | − 7.82 | Down |
| 2 | C8G | Complement C8 gamma chain | − 5.78 | Down |
| 3 | CR2 | Complement receptor type 2-like | 3.25 | Up |
| 4 | F2RL2 | Proteinase-activated receptor 3-like (coagulation factor II (thrombin) receptor) | 5.81 | Up |
| 5 | ITGB2 | Integrin beta-2-like | 3.0 | Up |
| 6 | PLAUR | Urokinase plasminogen activator surface receptor-like | − 3.17 | Down |
Notes: Chemokine signaling pathway has the predominant share of differentially expressed genes among the immune related pathways. Interestingly, most of the immune genes were upregulated in the T. bryosalmonae-exposed posterior kidney of brown trout
Fig. 5Validation of RNA-seq analysis by qRT-PCR on selected genes. The gene expression values are represented as relative fold change (mean ± SEM) of Tetracapsuloides bryosalmonae-exposed group compared to the unexposed control group (n = 6). The relative gene expression represented as the fold increase or decrease of the exposed group compared to the unexposed control group were calculated using 2−ΔΔCt method and the mean expression levels were adjusted to one
Fig. 6Linear regression plot between RNA-seq and qRT-PCR. The log2 fold change values for the RNA-seq and qRT-PCR are plotted along with the linear fit line showing a significant Pearsonʼs correlation coefficient r(10) = 0.968, P < 0.0001 and a coefficient of determination R2 = 0.937